Trials / Completed
CompletedNCT05366907
Open Cholecystectomy Among Patients Undergoing Laparoscopic Cholecystectomy.
Open Cholecystectomy Among Patients Undergoing Laparoscopic Cholecystectomy in a Tertiary Care Centre: A Descriptive Cross-Sectional Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 345 (actual)
- Sponsor
- Chitwan Medical College · Academic / Other
- Sex
- All
- Age
- 10 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
In the current era, laparoscopic cholecystectomy is the treatment of choice for symptomatic gallstone disease. The aim of this study is to find out the prevalence of open cholecystectomy among patients undergoing laparoscopic cholecystectomy in a tertiary care center.
Detailed description
Laparoscopic Cholecystectomy (LC) is the gold standard surgery for symptomatic cholelithiasis with low mortality and morbidity.1,2 However, 1% to 15% of conversion rate to Open Cholecystectomy (OC) during laparoscopic cholecystectomy has been reported.3 Converted cases were associated with increased perioperative time, complication rates, perioperative costs, the length of hospital stay, and a higher 30-day readmission rate.3,4 Conversion was also associated with complications including bile leak, bile duct injury, or bleeding, requiring reoperation or transfusion, and death. A recent detailed critical review found that preoperative variables like male gender, older age, high body mass index, previous abdominal surgery, the severity of cholecystitis, and gallbladder wall thickness were associated with the higher rate of conversion to OC.4 However, data regarding its prevalence lacking in our setting. The aim of this study is to find out the prevalence of open cholecystectomy among patients undergoing laparoscopic cholecystectomy in a tertiary care centre.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention is done | It is a descriptive cross-sectional study so no groups like case/controls are present. All the cases are included in the study. |
Timeline
- Start date
- 2020-06-01
- Primary completion
- 2021-05-30
- Completion
- 2021-12-30
- First posted
- 2022-05-09
- Last updated
- 2023-09-15
Locations
1 site across 1 country: Nepal
Source: ClinicalTrials.gov record NCT05366907. Inclusion in this directory is not an endorsement.